Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB)
- PMID: 30902030
- DOI: 10.1177/0272989X19837969
Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB)
Abstract
Cost-utility analysis (CUA) is a widely recommended form of health economic evaluation worldwide. The outcome measure in CUA is quality-adjusted life-years (QALYs), which are calculated using health state utility values (HSUVs) and corresponding life-years. Therefore, HSUVs play a significant role in determining cost-effectiveness. Formal adoption and endorsement of CUAs by reimbursement authorities motivates methodological advancement in HSUV measurement and application. A large body of evidence exploring various methods in measuring HSUVs has accumulated, imposing challenges for investigators in identifying and applying HSUVs to CUAs. First, large variations in HSUVs between studies are often reported, and these may lead to different cost-effectiveness conclusions. Second, issues concerning the quality of studies that generate HSUVs are increasingly highlighted in the literature. This issue is compounded by the limited published guidance and methodological standards for assessing the quality of these studies. Third, reimbursement decision making is a context-specific process. Therefore, while an HSUV study may be of high quality, it is not necessarily appropriate for use in all reimbursement jurisdictions. To address these issues, by promoting a systematic approach to study identification, critical appraisal, and appropriate use, we are developing the Health Utility Book (HUB). The HUB consists of an HSUV registry, a quality assessment tool for health utility studies, and a checklist for interpreting their use in CUAs. We anticipate that the HUB will make a timely and important contribution to the rigorous conduct and proper use of health utility studies for reimbursement decision making. In this way, health care resource allocation informed by HSUVs may reflect the preferences of the public, improve health outcomes of patients, and maintain the efficiency of health care systems.
Keywords: Health state utility value; applicability; health economic evaluation; health utility registry; quality assessment; quality-adjusted life year.
Similar articles
-
Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.Appl Health Econ Health Policy. 2021 Jan;19(1):29-44. doi: 10.1007/s40258-020-00600-w. Appl Health Econ Health Policy. 2021. PMID: 32661846
-
Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses.Breast Cancer Res Treat. 2017 Aug;164(3):527-536. doi: 10.1007/s10549-017-4283-8. Epub 2017 May 11. Breast Cancer Res Treat. 2017. PMID: 28497177 Review.
-
Health Utility Book (HUB)-Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer.MDM Policy Pract. 2019 Aug 13;4(2):2381468319852594. doi: 10.1177/2381468319852594. eCollection 2019 Jul-Dec. MDM Policy Pract. 2019. PMID: 31453359 Free PMC article.
-
Systematic searching and selection of health state utility values from the literature.Value Health. 2013 Jun;16(4):686-95. doi: 10.1016/j.jval.2013.02.017. Value Health. 2013. PMID: 23796303
-
Using health state utility values in models exploring the cost-effectiveness of health technologies.Value Health. 2012 Sep-Oct;15(6):971-4. doi: 10.1016/j.jval.2012.05.003. Epub 2012 Jun 15. Value Health. 2012. PMID: 22999149 Review.
Cited by
-
Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancer.Oncologist. 2025 Jul 4;30(7):oyae321. doi: 10.1093/oncolo/oyae321. Oncologist. 2025. PMID: 39589223 Free PMC article.
-
Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease.Med Decis Making. 2021 Aug;41(6):685-692. doi: 10.1177/0272989X211004532. Epub 2021 Apr 3. Med Decis Making. 2021. PMID: 33813938 Free PMC article.
-
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations.Pharmacoeconomics. 2024 Jul;42(7):767-782. doi: 10.1007/s40273-024-01365-z. Epub 2024 Mar 29. Pharmacoeconomics. 2024. PMID: 38551803 Free PMC article.
-
Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression.Health Qual Life Outcomes. 2024 Sep 7;22(1):74. doi: 10.1186/s12955-024-02288-1. Health Qual Life Outcomes. 2024. PMID: 39244536 Free PMC article.
-
Health utilities used in oncology cost-utility analyses: a registry-based analysis.Qual Life Res. 2025 Mar;34(3):801-807. doi: 10.1007/s11136-024-03856-0. Epub 2024 Nov 27. Qual Life Res. 2025. PMID: 39602020
MeSH terms
LinkOut - more resources
Full Text Sources